Estie is a Japanese real estate technology company that provides a SaaS platform to digitalize the flow of information and transactions in the commercial real estate market. The platform leverages a data infrastructure and a comprehensive real estate database to support services from pilot projects to full system development. It offers market research, rent estimation algorithms, and quantitative indicators to help clients make data-driven decisions. Founded in 2018 and based in Tokyo, Estie focuses on digital transformation in the commercial real estate sector.
Cellusion
Series C in 2023
Cellusion is a regenerative medicine company developing induced pluripotent stem cell-derived corneal endothelial cells for the treatment of bullous keratopathy. The company focuses on research, development, manufacturing, and commercial supply of corneal endothelial cell substitutes for transplantation to restore corneal function and vision. Originating from Keio University, Cellusion aims to enable scalable, cell-based therapies by cultivating corneal endothelial cells from iPS sources and delivering them for surgical transplantation. Based in Tokyo, Japan, the company emphasizes advancing regenerative ophthalmology through cell-based therapies that offer less invasive treatment options for patients with endothelial corneal disease.
Cellusion
Venture Round in 2022
Cellusion is a regenerative medicine company developing induced pluripotent stem cell-derived corneal endothelial cells for the treatment of bullous keratopathy. The company focuses on research, development, manufacturing, and commercial supply of corneal endothelial cell substitutes for transplantation to restore corneal function and vision. Originating from Keio University, Cellusion aims to enable scalable, cell-based therapies by cultivating corneal endothelial cells from iPS sources and delivering them for surgical transplantation. Based in Tokyo, Japan, the company emphasizes advancing regenerative ophthalmology through cell-based therapies that offer less invasive treatment options for patients with endothelial corneal disease.
Capex
Venture Round in 2021
Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.
Startbahn
Series B in 2021
Founded in Tokyo in 2014, Startbahn operates a blockchain-based platform focused on enhancing the art industry globally. It specializes in issuing blockchain certificates for artwork authentication and traceability via its Startbahn Cert service. Additionally, it develops Startrail, a blockchain infrastructure supporting Startbahn Cert, and collaborates with other companies on joint projects.
Capex
Venture Round in 2020
Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.
Japan Data Science Consortium
Series B in 2020
Japan Data Science Consortium Co. is a Tokyo-based company specializing in artificial intelligence, Internet of Things, and robotic services. Established in 2014, JDSC offers a range of solutions including demand forecasting, predictive maintenance, and digital transformation. The company also focuses on zero re-delivery systems, optical character recognition, and image recognition services. Targeting sectors such as healthcare, education, and retail, JDSC provides comprehensive consulting support that encompasses system construction and organizational process transformation, all aimed at generating tangible profit through the effective use of AI technology.
Epigeneron
Series B in 2020
Epigeneron, Inc. is a biotechnology company based in Chuo, Japan, founded in 2015. The company focuses on the research, development, manufacturing, and marketing of pharmaceutical drugs, particularly in the areas of cancer, dementia, metabolic disorders, and infectious diseases. Epigeneron specializes in drug discovery, offering services that include the development of epigenetic and antimicrobial drugs. The company employs advanced techniques such as chromatin immunoprecipitation to isolate specific genomic regions, thereby facilitating the identification of molecules that interact with these regions. This innovative approach enables the development of gene therapies aimed at treating severe immune diseases and other serious health conditions, including fibrosis and disorders of the central nervous system. Additionally, Epigeneron is involved in the manufacture and sale of research reagents, diagnostic agents, and research equipment, alongside supporting drug discovery efforts through information services and intellectual property transfer.
BionicM is a Tokyo‑based company that develops robotic prostheses for lower‑limb amputees. Its products include powered knee joints and ankle‑foot devices that mimic natural muscle function, allowing users to stand, walk, and climb stairs with reduced effort. The company’s technology was first researched in 2015 at the University of Tokyo’s Information Systems Engineering Laboratory and received support from the Japan Science and Technology Agency in 2016. BionicM was formally established in 2018 and continues to advance high‑performance prosthetic solutions that enhance mobility for people with disabilities.
Estie is a Japanese real estate technology company that provides a SaaS platform to digitalize the flow of information and transactions in the commercial real estate market. The platform leverages a data infrastructure and a comprehensive real estate database to support services from pilot projects to full system development. It offers market research, rent estimation algorithms, and quantitative indicators to help clients make data-driven decisions. Founded in 2018 and based in Tokyo, Estie focuses on digital transformation in the commercial real estate sector.
Goryo Chemical
Venture Round in 2019
Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.
Retrieva
Venture Round in 2019
Retrieva is a Tokyo-based developer of AI software for call centers, combining natural language processing and machine learning to analyze inquiries and assist with responses for enterprise clients. The company focuses on research, development, and ongoing support of ML-driven software, and its product family includes Talk Coordinator, an operator software solution; Voice Visualizer, an administrator software solution; and VoC Analyzer, an analysis software solution. Founded in 2016, Retrieva serves organizations seeking scalable, AI-powered customer service solutions.
Mujin
Venture Round in 2019
Mujin is a Tokyo-based company that develops intelligent robot controllers and factory automation solutions for industrial robotics. It provides a universal controller platform that integrates motion planning with machine vision and programmable logic controllers to automate heavy and repetitive tasks in logistics and manufacturing. The company offers products such as Mujin Controller Sim, a platform for programming industrial robots; Mujin Scanner, which creates 3D models of objects or environments; Pick Worker, a bin-picking system with real-time motion planning; and Laser Worker, a laser cutting system powered by motion planning. In addition to hardware and software tools, Mujin supplies services in robot and controller design, teaching and simulation, legacy-system support, and system integration. Its technology focuses on optimizing offline motions and enabling real-time operation across complex workflows, reducing dependence on manual handling in dynamic industrial settings.
Startbahn
Series A in 2019
Founded in Tokyo in 2014, Startbahn operates a blockchain-based platform focused on enhancing the art industry globally. It specializes in issuing blockchain certificates for artwork authentication and traceability via its Startbahn Cert service. Additionally, it develops Startrail, a blockchain infrastructure supporting Startbahn Cert, and collaborates with other companies on joint projects.
Estie is a Japanese real estate technology company that provides a SaaS platform to digitalize the flow of information and transactions in the commercial real estate market. The platform leverages a data infrastructure and a comprehensive real estate database to support services from pilot projects to full system development. It offers market research, rent estimation algorithms, and quantitative indicators to help clients make data-driven decisions. Founded in 2018 and based in Tokyo, Estie focuses on digital transformation in the commercial real estate sector.
BionicM
Seed Round in 2019
BionicM is a Tokyo‑based company that develops robotic prostheses for lower‑limb amputees. Its products include powered knee joints and ankle‑foot devices that mimic natural muscle function, allowing users to stand, walk, and climb stairs with reduced effort. The company’s technology was first researched in 2015 at the University of Tokyo’s Information Systems Engineering Laboratory and received support from the Japan Science and Technology Agency in 2016. BionicM was formally established in 2018 and continues to advance high‑performance prosthetic solutions that enhance mobility for people with disabilities.
Neural Pocket
Venture Round in 2018
Founded in 2018, Neural Pocket specializes in developing proprietary AI technologies for image and video detection, classification, and behavior analysis. The company offers services for smart city development, facility management, digital signage, and fashion trend analysis.
AI Inside
Venture Round in 2018
Founded in Tokyo, Japan in 2015, AI Inside specializes in software development and artificial intelligence. It offers DX Suite, an AI-powered Optical Character Recognition (OCR) platform, transforming information into digital data to enhance productivity.
Startbahn
Seed Round in 2018
Founded in Tokyo in 2014, Startbahn operates a blockchain-based platform focused on enhancing the art industry globally. It specializes in issuing blockchain certificates for artwork authentication and traceability via its Startbahn Cert service. Additionally, it develops Startrail, a blockchain infrastructure supporting Startbahn Cert, and collaborates with other companies on joint projects.
Fressets
Corporate Round in 2018
Fressets, Inc., established in 2017 and based in Tokyo, Japan, specializes in developing cryptocurrency wallet systems for virtual currency exchanges. The company's core business is an enterprise wallet management (EWM) system, primarily serving cryptocurrency exchanges and custodians. This system employs multisignature addresses and secure hardware for key storage, ensuring robust security against hacker threats. It combines the advantages of secure cold wallets and convenient hot wallets, providing clients with a balance of security and scalability for smooth cryptocurrency transactions.
Founded in 2014, Aidemy offers an online platform for individuals to learn artificial intelligence programming and for businesses to leverage AI technology using their own data. Its services include practical blockchain applications, supporting DX human resource development, problem selection, proof-of-concept development, and operation.
Epigeneron
Venture Round in 2018
Epigeneron, Inc. is a biotechnology company based in Chuo, Japan, founded in 2015. The company focuses on the research, development, manufacturing, and marketing of pharmaceutical drugs, particularly in the areas of cancer, dementia, metabolic disorders, and infectious diseases. Epigeneron specializes in drug discovery, offering services that include the development of epigenetic and antimicrobial drugs. The company employs advanced techniques such as chromatin immunoprecipitation to isolate specific genomic regions, thereby facilitating the identification of molecules that interact with these regions. This innovative approach enables the development of gene therapies aimed at treating severe immune diseases and other serious health conditions, including fibrosis and disorders of the central nervous system. Additionally, Epigeneron is involved in the manufacture and sale of research reagents, diagnostic agents, and research equipment, alongside supporting drug discovery efforts through information services and intellectual property transfer.
Neural Pocket
Seed Round in 2018
Founded in 2018, Neural Pocket specializes in developing proprietary AI technologies for image and video detection, classification, and behavior analysis. The company offers services for smart city development, facility management, digital signage, and fashion trend analysis.
Founded in 2014, Aidemy offers an online platform for individuals to learn artificial intelligence programming and for businesses to leverage AI technology using their own data. Its services include practical blockchain applications, supporting DX human resource development, problem selection, proof-of-concept development, and operation.
FLOSFIA
Venture Round in 2017
FLOSFIA INC. is a Tokyo-based company that focuses on the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the company emerged as a spin-off from research conducted at Kyoto University. FLOSFIA specializes in film-formation using mist chemical vapor deposition (CVD) techniques, leveraging the unique physical properties of gallium oxide (Ga2O3) to create high breakdown voltage and high efficiency power devices. The firm is dedicated to advancing low-loss power device technology, contributing to the evolution of semiconductor applications.
Retrieva
Venture Round in 2017
Retrieva is a Tokyo-based developer of AI software for call centers, combining natural language processing and machine learning to analyze inquiries and assist with responses for enterprise clients. The company focuses on research, development, and ongoing support of ML-driven software, and its product family includes Talk Coordinator, an operator software solution; Voice Visualizer, an administrator software solution; and VoC Analyzer, an analysis software solution. Founded in 2016, Retrieva serves organizations seeking scalable, AI-powered customer service solutions.
Goryo Chemical
Venture Round in 2016
Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.
SEAOS
Venture Round in 2016
SEAOS, Inc. is a Tokyo-based company founded in 2000 that specializes in developing software applications for the logistics industry. In addition to software development, SEAOS provides business consulting services focused on logistics strategy and product licensing. The company is also involved in the development of robotics solutions, enhancing operational efficiency within the logistics sector. With its comprehensive approach to logistics and technology, SEAOS aims to support businesses in navigating the complexities of modern supply chain management.
Liquid, Inc. is a Tokyo-based company founded in 2013 that specializes in the manufacture and development of biometric identity verification and payment devices. The company focuses on fingerprint sensing technology, which enables users to register payment methods, such as point cards and credit cards, using their fingerprint information. This innovative approach allows customers to complete transactions simply by using their fingerprints. Liquid also develops related software that employs advanced authentication algorithms and image analysis technology to enhance security and convenience in payment processes.
MONEY DESIGN
Venture Round in 2015
MONEY DESIGN Co., Ltd. is a fintech company based in Tokyo, Japan, founded in 2013. The firm specializes in asset management and investment advisory services, providing automated investment management solutions to its clients. By leveraging technology, MONEY DESIGN aims to simplify the investment process and make financial advice more accessible to a broader audience.
FLOSFIA
Venture Round in 2015
FLOSFIA INC. is a Tokyo-based company that focuses on the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the company emerged as a spin-off from research conducted at Kyoto University. FLOSFIA specializes in film-formation using mist chemical vapor deposition (CVD) techniques, leveraging the unique physical properties of gallium oxide (Ga2O3) to create high breakdown voltage and high efficiency power devices. The firm is dedicated to advancing low-loss power device technology, contributing to the evolution of semiconductor applications.
Crewt Medical Systems
Venture Round in 2015
Crewt Medical Systems, established in Tokyo, Japan in 2013, specializes in manufacturing innovative medical devices. The company's flagship product is the world's first head-mounted perimeter, designed to meet clinical needs and compatible with standard automated perimeters. Crewt's mission is to create new value in healthcare by integrating advanced technologies, focusing on human-centric solutions that enhance visual quality.
Seven Dreamers
Series A in 2015
Seven Dreamers Laboratories, Inc. is a Tokyo-based company that specializes in designing and manufacturing innovative medical devices and personal-use technology. Founded in 2011, the company is known for its commitment to developing unique, world-first products. One of its notable creations is the Laundroid, a laundry-folding robot that employs image-recognition algorithms and artificial intelligence to identify various types of clothing, fold them accordingly, and sort them by item or family member. This technology aims to significantly enhance everyday life by automating household chores, thereby allowing users to spend their time on more meaningful activities.
Vegetalia
Venture Round in 2015
Vegetalia, Inc. is an agricultural technology company based in Tokyo, Japan, established in 2010. The company specializes in developing and marketing measurement monitoring systems and cloud-based application solutions tailored for the agricultural industry. Its flagship products include FieldServer, which integrates field sensors with web and mobile applications for outdoor monitoring, and PaddyWatch, a water management system specifically designed for rice cultivation. Additionally, Vegetalia offers agri-note, a cloud service that supports field management and work analysis. The company employs IoT technology and data analytics to optimize farming practices, enabling agricultural professionals and farmers to efficiently monitor and manage their fields. Vegetalia also operates plant clinics, further enhancing its commitment to sustainable agricultural practices.
Goryo Chemical
Series B in 2015
Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.
Cyfuse Biomedical
Venture Round in 2015
Cyfuse Biomedical specializes in developing tissue fabrication systems and cell-based products for global research institutions. It offers a robotic 3D BioFabrication system, producing various tissue grafts for therapeutic use, drug development, and research purposes. Founded in 2010, the company is headquartered in Tokyo, Japan.
Molcure is a biopharmaceutical company focused on antibody and peptide drug discovery. The company combines expertise in next-generation sequencing, bioinformatics, and antibody biology with an automated discovery system to identify high-quality antibody candidates and peptide therapeutics, aiming to shorten research and development timelines for pharmaceutical partners. Its Abtracer platform provides antibody sequence screening to detect functional candidates, and its SmartLabModule integrates IoT-enabled laboratory workflows to support efficient science. Through in-house capabilities and partnerships, Molcure seeks to advance therapeutic antibodies and related therapies, focusing on improving patient outcomes. Founded in 2013 and based in Tokyo, Molcure positions itself as a partner for therapeutic antibody discovery, offering automation and knowledge to accelerate discovery processes.
Mujin is a Tokyo-based company that develops intelligent robot controllers and factory automation solutions for industrial robotics. It provides a universal controller platform that integrates motion planning with machine vision and programmable logic controllers to automate heavy and repetitive tasks in logistics and manufacturing. The company offers products such as Mujin Controller Sim, a platform for programming industrial robots; Mujin Scanner, which creates 3D models of objects or environments; Pick Worker, a bin-picking system with real-time motion planning; and Laser Worker, a laser cutting system powered by motion planning. In addition to hardware and software tools, Mujin supplies services in robot and controller design, teaching and simulation, legacy-system support, and system integration. Its technology focuses on optimizing offline motions and enabling real-time operation across complex workflows, reducing dependence on manual handling in dynamic industrial settings.
Nabiq Inc. offers outsourcing services tailored for wireless broadband environments, focusing on the integration of existing fixed broadband lines with Wi-Fi technology. The company specializes in designing radio zones, installing, and operating wireless broadband solutions for various local settings, including hotels, hospitals, condominiums, and schools. Its cloud-based platform facilitates secure network connectivity for smartphones and tablets, creating a seamless access environment. Founded in 2013 and headquartered in Chiyoda, Japan, Nabiq operates as a subsidiary of JTOWER Inc.
MONEY DESIGN
Seed Round in 2014
MONEY DESIGN Co., Ltd. is a fintech company based in Tokyo, Japan, founded in 2013. The firm specializes in asset management and investment advisory services, providing automated investment management solutions to its clients. By leveraging technology, MONEY DESIGN aims to simplify the investment process and make financial advice more accessible to a broader audience.
Cyfuse Biomedical
Series A in 2013
Cyfuse Biomedical specializes in developing tissue fabrication systems and cell-based products for global research institutions. It offers a robotic 3D BioFabrication system, producing various tissue grafts for therapeutic use, drug development, and research purposes. Founded in 2010, the company is headquartered in Tokyo, Japan.
Prometech Software
Corporate Round in 2012
Prometech Software, Inc. is a technology company based in Tokyo, Japan, founded in 2004. It specializes in the development of virtual reality technologies, focusing on interactive experiences through advanced physics simulation software and computer graphics. The company offers innovative computer-aided engineering (CAE) solutions, particularly in fluid simulation using the Particle Method, which aids in product development by providing detailed fluid analysis and facilitating the construction of 3D environments. Prometech Software is dedicated to enhancing user interactivity within virtual realities, making significant contributions to the fields of simulation and virtual technology.
Mujin is a Tokyo-based company that develops intelligent robot controllers and factory automation solutions for industrial robotics. It provides a universal controller platform that integrates motion planning with machine vision and programmable logic controllers to automate heavy and repetitive tasks in logistics and manufacturing. The company offers products such as Mujin Controller Sim, a platform for programming industrial robots; Mujin Scanner, which creates 3D models of objects or environments; Pick Worker, a bin-picking system with real-time motion planning; and Laser Worker, a laser cutting system powered by motion planning. In addition to hardware and software tools, Mujin supplies services in robot and controller design, teaching and simulation, legacy-system support, and system integration. Its technology focuses on optimizing offline motions and enabling real-time operation across complex workflows, reducing dependence on manual handling in dynamic industrial settings.
Phyzios
Venture Round in 2011
Phyzios is a software company based at the University of Tokyo, established in January 2009. It specializes in developing gaming applications that utilize advanced physical simulation technology, allowing materials to be treated as particles with varying properties. This innovative approach enables developers to create interactive experiences for touch panel devices. Phyzios has achieved notable success in the mobile application market, with several of its iPhone and iPod touch applications ranking among the top 10 in their respective categories on the Japanese App Store. Notably, its application PHYZIOS Sculptor ranked as the second most popular free application in Japan and first in Italy. As a spin-off from Prometech Software, Inc., Phyzios continues to focus on enhancing user engagement through its unique simulation capabilities.
PopIn
Venture Round in 2008
PopIn Inc. is a Tokyo-based company founded in July 2008 by Cheng Tao, specializing in online advertising services. The company focuses on developing tools that allow users to measure the effectiveness of advertisements by comparing the estimated reading time of an ad with the time spent by users on a website. PopIn's mission is to enhance the browsing experience for internet users by integrating information in a way that effectively addresses their needs. As of May 2015, PopIn operates as a subsidiary of Baidu Japan, Inc.
Lifenet Insurance
Venture Round in 2008
Lifenet Insurance Company is a life insurance provider based in Tokyo, Japan, established in 2006. The company specializes in underwriting a variety of insurance products, including term death, whole life, medical, cancer, and disability insurance. Lifenet also offers health counseling services, catering to the diverse needs of its clientele. Notably, the company sells its products directly to consumers through the Internet, enhancing accessibility and customer engagement.
tella
Venture Round in 2007
Founded in Tokyo, Japan in 2004, tella specializes in the research and development of regenerative and cell medicines, with a focus on dendritic cell vaccine therapy for cancer treatment. The company offers operational support to affiliated medical institutions, including consultation services for establishing cell processing centers, training technicians, and supporting therapies assessment.
NanoCarrier
Venture Round in 2007
NanoCarrier Co., Ltd. is a pharmaceutical company based in Kashiwa, Japan, specializing in the research, development, production, and sale of pharmaceutical products utilizing micellar nanoparticle technology. Founded in 1996, the company focuses primarily on cancer treatments, boasting a diverse product pipeline that includes NC-6004, a Cisplatin micelle targeting various cancers such as pancreatic and non-small cell lung cancer; VB-111, an Adeno 5 vector designed for rGBM and ovarian cancer; and NC-6300, which utilizes Epirubicin micelle for soft tissue sarcoma. Additional offerings include NC-4016, a Dach-platinum micelle for solid tumors, and NK105, a Paclitaxel micelle aimed at breast and gastric cancers. With a commitment to advancing cancer therapeutics, NanoCarrier continues to innovate in the pharmaceutical industry.
tella
Venture Round in 2005
Founded in Tokyo, Japan in 2004, tella specializes in the research and development of regenerative and cell medicines, with a focus on dendritic cell vaccine therapy for cancer treatment. The company offers operational support to affiliated medical institutions, including consultation services for establishing cell processing centers, training technicians, and supporting therapies assessment.
tella
Venture Round in 2005
Founded in Tokyo, Japan in 2004, tella specializes in the research and development of regenerative and cell medicines, with a focus on dendritic cell vaccine therapy for cancer treatment. The company offers operational support to affiliated medical institutions, including consultation services for establishing cell processing centers, training technicians, and supporting therapies assessment.